Company page
Prostatype Genomics Ab
Prostatype Genomics Ab, traded under the ticker PROGEN, is a public company based in Sweden. With a market capitalization of approximately 3.95 million USD, the company focuses on advancements in genomics related to prostate health. Their innovative approach aims to improve patient outcomes through personalized medicine.
- Ticker
- PROGEN:OMXSTO
- Asset type
- Stock
- Market cap
- $4.0M
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- OMXSTO
- Currency
- SEK